BDRX
BIODEXA (BDRX) Cuts Warrant Price to $1.05 to Raise $2.3 Million
The UK biotech induced a single holder to exercise all Series M, N and O warrants at a reduced price, issuing 2.2 million ADSs plus two replacement warrants each.
BDRX
Market-moving news on Biodexa Pharmaceuticals (NASDAQ: BDRX): filings, earnings, deals and other events, from REDFILED.